Abstract

Developmental Medicine & Child NeurologyVolume 43, Issue 4 p. 286-287 Free Access ‘Cerebrospinal fluid neuropeptide Y in Prader-Willi syndrome’ Arne Åkefeldt MD PhD, Corresponding Author Arne Åkefeldt MD PhD Department of Psychiatry and Neurochemistry, Institute of Clinical Neuroscience, Göteborg University, Sahlgren University Hospital/Mölndal, SE-43180 Mölndal, SwedenCorresponding author Child and Adolescent Psychiatry Skaraborg Hospital Drottninggatan 3 A SE-542 34 Mariestad SwedenSearch for more papers by this authorRolf Ekman MD PhD, Rolf Ekman MD PhD Department of Psychiatry and Neurochemistry, Institute of Clinical Neuroscience, Göteborg University, Sahlgren University Hospital/Mölndal, SE-43180 Mölndal, SwedenSearch for more papers by this authorJan-Eric Månsson PhD, Jan-Eric Månsson PhD Department of Psychiatry and Neurochemistry, Institute of Clinical Neuroscience, Göteborg University, Sahlgren University Hospital/Mölndal, SE-43180 Mölndal, SwedenSearch for more papers by this author Arne Åkefeldt MD PhD, Corresponding Author Arne Åkefeldt MD PhD Department of Psychiatry and Neurochemistry, Institute of Clinical Neuroscience, Göteborg University, Sahlgren University Hospital/Mölndal, SE-43180 Mölndal, SwedenCorresponding author Child and Adolescent Psychiatry Skaraborg Hospital Drottninggatan 3 A SE-542 34 Mariestad SwedenSearch for more papers by this authorRolf Ekman MD PhD, Rolf Ekman MD PhD Department of Psychiatry and Neurochemistry, Institute of Clinical Neuroscience, Göteborg University, Sahlgren University Hospital/Mölndal, SE-43180 Mölndal, SwedenSearch for more papers by this authorJan-Eric Månsson PhD, Jan-Eric Månsson PhD Department of Psychiatry and Neurochemistry, Institute of Clinical Neuroscience, Göteborg University, Sahlgren University Hospital/Mölndal, SE-43180 Mölndal, SwedenSearch for more papers by this author First published: 02 March 2007 https://doi.org/10.1111/j.1469-8749.2001.tb00205.xCitations: 1AboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onFacebookTwitterLinkedInRedditWechat No abstract is available for this article. References 1 Holm VA, Cassidy SB, Butler MG, Hanchett JM, Greenswag LR, Whitman BY, Greenberg R. (1993) Prader-Willi syndrome: consensus diagnostic criteria. Pediatrics 91: 398– 402. 2 Åkefeldt A, Ekman R, Gillberg C, Månsson J-E. (1998) Cerebrospinal fluidmonoamines in Prader-Willi syndrome. Biological Psychiatry 44: 1321– 8. 3 Åkefeldt A, Månsson J-E. (1998) Is monoamine oxidase activity elevated in Prader-Willi syndrome European Child & Adolescent Psychiatry 7: 163– 5. 4 Åkefeldt A, Törnhage C-J, Gillberg C. (1999) A woman with Prader-Willi syndrome gives birth to a healthy baby girl. Developmental Medicine & Child Neurology 41: 789– 90. 5 Leibowitz SF. (1986) Brain monoamines and peptides: role in the control of eating behavior. Federation Proceedings 45: 1396– 1403. 6 Lehnert H, Wurtman RJ. (1993) Amino acid control of neurotransmitter synthesis and release: physiological and clinical implications. Psychotherapy and Psychosomatics 60: 18– 32. 7 Dryden S, McCarthy HD, Malabu UH, Ware M, Williams G. (1993) Increased neuropeptide Y concentrations in specific hypothalamic nuclei of the rat following treatment with methysergide: evidence that NPY may mediate serotonin's effects on food intake. Peptides 14: 791– 6. 8 Reis A, Dittrich B, Greger Y, Buiting K, Lalande M, Gillessen-Kaesbach G, Anvret M, Horsthemke B. (1992) Imprinting mutations suggested by abnormal DNA methylation pattern in familial Angelman and Prader-Willi syndromes. American Journal of Human Genetics 54: 741– 7. 9 Widerlöv E, Lindström LH, Wahlestedt C, Ekman R. (1988) Neuropeptide Y and peptide YY as possible cerebrospinal fluid markers for major depression and schizophrenia, respectively. Journal of Psychiatric Research 22: 69– 79. Citing Literature Volume43, Issue4April 2001Pages 286-287 ReferencesRelatedInformation

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.